Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-Severe Plaque Psoriasis”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01961609
What this trial is testing

Secukinumab in Tumor Necrosis Factor (TNF) - Inadequate Response (IR) Psoriasis Participants.

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 235
Post-approval studies (Phase 4)Study completedNCT02412644
What this trial is testing

Apremilast 30mg Bid With Narrowband UVB in the Treatment of Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Psoriasis Treatment Center of Central New Jersey 29
Testing effectiveness (Phase 2)Study completedNCT04207801
What this trial is testing

A Phase II Study to Evaluate Efficacy & Safety of AUR101 in Patients of Moderate-to-Severe Psoriasis

Who this might be right for
Chronic Plaque-type Psoriasis
Aurigene Discovery Technologies Limited 90
Early research (Phase 1)UnknownNCT03710681
What this trial is testing

A Safety Study of Multiple Subcutaneous (s.c.) Injections of SHR-1314 in Adults With Moderate-to-severe Plaque Psoriasis

Who this might be right for
Moderate-to-severe Plaque Psoriasis
Jiangsu HengRui Medicine Co., Ltd. 16
Large-scale testing (Phase 3)WithdrawnNCT01815723
What this trial is testing

Efficacy Study on Dimethyl Fumarate to Treat Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Forward-Pharma GmbH
Large-scale testing (Phase 3)Study completedNCT04728360
What this trial is testing

Comparative Study of BAT2206 With Stelara® in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Bio-Thera Solutions 556
Testing effectiveness (Phase 2)Study completedNCT00687362
What this trial is testing

Evaluate Remicade (Infliximab) in Moderate-to-Severe Chronic Plaque Psoriasis in the Middle Eastern Population (Study P04528)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 22
Not applicableStudy completedNCT03757013
What this trial is testing

Assess Benefits of Apremilast in Patients With Moderate to Severe Chronic Plaque Psoriasis Followed by Dermatologists Under Real Life Settings in France

Who this might be right for
Psoriasis
Amgen 453
Testing effectiveness (Phase 2)Study completedNCT05364554
What this trial is testing

A Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Janssen Research & Development, LLC 227
Testing effectiveness (Phase 2)Study completedNCT01107457
What this trial is testing

A Study in Participants With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Eli Lilly and Company 142
Large-scale testing (Phase 3)Study completedNCT03897075
What this trial is testing

Efficacy and Safety Study of Tildrakizumab in the Treatment of Nail Psoriasis

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Nail Psoriasis
Sun Pharmaceutical Industries Limited 99
Testing effectiveness (Phase 2)Study completedNCT01987843
What this trial is testing

Dose-finding Study of MT-1303 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Tanabe Pharma Corporation 142
Large-scale testing (Phase 3)Study completedNCT00658788
What this trial is testing

Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque Psoriasis

Who this might be right for
Psoriasis
Galderma R&D 305
Not applicableStudy completedNCT03236870
What this trial is testing

Evaluate the Effectiveness and Patient-Reported Outcome of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in China

Who this might be right for
Psoriasis
AbbVie 181
Testing effectiveness (Phase 2)Study completedNCT01096862
What this trial is testing

Explore Efficacy and Safety of ASP015K in Subjects With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Astellas Pharma Inc 124
Testing effectiveness (Phase 2)Study completedNCT01855880
What this trial is testing

Phase IIa Study of Multiple Doses of AbGn-168H by iv Infusion in Moderate to Severe Chronic Plaque Psoriasis Patients

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
AbGenomics B.V Taiwan Branch 54
Testing effectiveness (Phase 2)Study completedNCT01072383
What this trial is testing

Safety and Efficacy of Multiple Doses of BT061 in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis Vulgaris
Biotest 49
Large-scale testing (Phase 3)Study completedNCT03766685
What this trial is testing

Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Moderate to Severe Chronic Plaque Psoriasis (PSO)

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Chronic Plaque Psoriasis
UCB Biopharma SRL 172
Post-approval studies (Phase 4)Study completedNCT00249808
What this trial is testing

Efalizumab in Participants With Moderate to Severe Chronic Psoriasis Who Have Failed, Have a Contraindication to, or Are Intolerant of Other Systemic Therapies

Who this might be right for
Psoriasis
Merck KGaA, Darmstadt, Germany 1,266
Early research (Phase 1)Study completedNCT03718884
What this trial is testing

Mirikizumab in Participants With Plaque Psoriasis

Who this might be right for
Psoriasis
Eli Lilly and Company 29
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation